Technest Holdings Subsidiary, Genex Technologies Awarded SBIR Contract by National Institutes of Health Wednesday October 12, 8:00 am ET
BOSTON--(BUSINESS WIRE)--Oct. 12, 2005--Markland Technologies, Inc. (OTCBB:MRKL - News) and its subsidiary Technest Holdings, Inc. (OTC BB:TCNH.OB - News), defense and homeland security companies transforming advanced laboratory technology into real-world products, announced today that Genex Technologies Inc. (www.genextech.com) has been awarded a Small Business Innovation Research (SBIR) contract by the National Institutes of Health (NIH) to develop a novel 3D technology to reconstruct the human intestinal canal in 3D from images captured by video capsule endoscopes. ADVERTISEMENT
NIH is the nation's medical research agency - making important medical discoveries that improve health and save lives. The National Institutes of Health, is the primary Federal agency for conducting and supporting medical research. It is composed of 27 institutes and centers which provide leadership and financial support to medical researchers in every state within the US.
Genex Technologies innovations in 3D image processing will allow for the reconstructed 3D shape obtained by these endoscopic capsules to help physicians locate the position of an intestinal lesion and measure its volume. Video capsule endoscopy is a new technology which revolutionizes the diagnosis and treatment of gastrointestinal diseases. Conventional endoscopy tests, such as gastroscopy and colonoscopy, are effective for the upper or lower digestive tract, but achieve very limited success in the 20 feet of small intestine where endoscopic instruments are hard to control and manipulate.
This new imaging technology will bring medical endoscopic intervention into a new era. To overcome current challenges, Genex is developing a novel 3D image processing technology which includes the following capabilities:
Re-construction of the 3D shape of the intestinal canal from video sequences captured by video capsules. Post-processing software tools which will facilitate the storage and measurement of the reconstructed 3D shape. A simulation platform which can quantitatively evaluate the accuracy of the 3D algorithms. Genex Technologies, Inc. has been providing innovative 3D products and services to customers within the National Institutes of Health since its inception in 1995.
About Markland Technologies
Markland Technologies, Inc. is committed to setting next-generation standards in defense and security through the provision of innovative emerging technologies and expert services. The Company is engaged in the identification of advanced technologies currently under development in laboratories, universities and in private industry, and in the transformation of those technologies into next-generation products. Markland's solutions support military, law enforcement and homeland security personnel to protect the nation's citizens, borders and critical infrastructure assets from the threat of terrorism and other dangers. Through strategic development, Markland focuses on the creation of dual-use technology and products with applications in both the defense market and civilian homeland security and law enforcement fields. The Company is a Board Member of the Homeland Security Industries Association, and is a featured Company on *********************.com; additional details can be viewed at http://www.*********************.com/Companies/MarklandTech. For more information about the Company and its products, please visit the Markland home page at http://www.marklandtech.com.Posts: 134 | From: San Jose, CA | Registered: Jun 2005
| IP: Logged |
Technest Holdings Subsidiary, Genex Technologies, Earns Small Business Innovation Research Contract by National Institutes of Health for 3D Imaging Technology Wednesday October 12, 11:00 am ET
BOSTON, Oct. 12, 2005 (PRIMEZONE) -- Markland Technologies, Inc. (OTC BB:MRKL.OB - News) and its subsidiary Technest Holdings, Inc. (OTC BB:TCNH.OB - News), defense and homeland security companies transforming advanced laboratory technology into real-world products, announced today that Genex Technologies Inc. (http://www.genextech.com) has been awarded a Small Business Innovation Research (SBIR) contract by the National Institutes of Health (NIH) to develop a novel 3D technology to reconstruct the human intestinal canal in 3D from images captured by video capsule endoscopes. ADVERTISEMENT
NIH is the nation's medical research agency -- making important medical discoveries that improve health and save lives. The National Institutes of Health is the primary Federal agency for conducting and supporting medical research. It is composed of 27 institutes and centers which provide leadership and financial support to medical researchers in every state within the U.S.
Genex Technologies innovations in 3D image processing will allow for the reconstructed 3D shape obtained by these endoscopic capsules to help physicians locate the position of an intestinal lesion and measure its volume. Video capsule endoscopy is a new technology which revolutionizes the diagnosis and treatment of gastrointestinal diseases. Conventional endoscopy tests, such as gastroscopy and colonoscopy, are effective for the upper or lower digestive tract, but achieve very limited success in the 20 feet of small intestine where endoscopic instruments are hard to control and manipulate.
This new imaging technology will bring medical endoscopic intervention into a new era. To overcome current challenges, Genex is developing a novel 3D image processing technology which includes the following capabilities:
-- Reconstruction of the 3D shape of the intestinal canal from video sequences captured by video capsules.
-- Post-processing software tools which will facilitate the storage and measurement of the reconstructed 3D shape.
-- A simulation platform which can quantitatively evaluate the accuracy of the 3D algorithms.
Genex Technologies, Inc. has been providing innovative 3D products and services to customers within the National Institutes of Health since its inception in 1995.
About Markland Technologies
Markland Technologies, Inc. is committed to setting next-generation standards in defense and security through the provision of innovative emerging technologies and expert services. The Company is engaged in the identification of advanced technologies currently under development in laboratories, universities and in private industry, and in the transformation of those technologies into next-generation products. Markland's solutions support military, law enforcement and homeland security personnel to protect the nation's citizens, borders and critical infrastructure assets from the threat of terrorism and other dangers. Through strategic development, Markland focuses on the creation of dual-use technology and products with applications in both the defense market and civilian homeland security and law enforcement fields. The Company is a Board Member of the Homeland Security Industries Association, and is a featured Company on *********************.com; additional details can be viewed at http://www.*********************.com/Companies/MarklandTech. For more information about the Company and its products, please visit the Markland home page at http://www.marklandtech.com.
About Technest Holdings, Inc.
Posts: 134 | From: San Jose, CA | Registered: Jun 2005
| IP: Logged |
posted
MRKL has a huge backlog of business from the armed forces, great technology but dilution has killed the pps the last few months. Use to sell for over a dollar. They are supposedly building a suicide detection system that if true and the gov't buys it, would be huge!!!
Posts: 424 | From: Baltimore, MD | Registered: Apr 2004
| IP: Logged |
posted
Think this is looking good at these levels. I'm in 40000 at .025 Maybe i'll see there suicie detection system at my work sometime in the future. Sounds good to me.
Posts: 113 | From: New England | Registered: Jul 2005
| IP: Logged |
posted
Might just have to keep some shares in this and see if the gov't buys come in. Thanks
Posts: 134 | From: San Jose, CA | Registered: Jun 2005
| IP: Logged |
Company Releases for Markland Technologies Inc Wednesday, October 12, 2005
Technest Holdings Subsidiary, Genex Technologies, Earns Small Business Innovation Research Contract by National Institutes of Health for 3D Imaging Technology - PrimeZone 11:00 AM
Technest Holdings Subsidiary, Genex Technologies Awarded SBIR Contract by National Institutes of Health - BusinessWire 8:00 AM
-------------------- It is always darkest before it goes completely BLACK!!! Posts: 2322 | From: FL | Registered: Aug 2004
| IP: Logged |
RESULTS OF OPERATIONS COMPARISON OF FISCAL 2005 AND FISCAL 2004 REVENUE:
Revenue for the fiscal year ended June 30, 2005 was $66,694,787 compared to $6,013,930 for the same period in 2004.
For the fiscal year ended June 30, 2005, approximately 97% of our revenue was from EOIR, with 84% from our Omnibus Contract with the United States Army Night Vision and Electronic Sensors Directorate. Revenues from grants related to 3D imaging technology from our newly acquired Genex subsidiary and sales of ACADA products and border security products and services each represented approximately 1.5% of our revenue.
For the fiscal year ended June 30, 2004, approximately 80% or our revenue was from our chemical detection business, including sales of the ACADA product, approximately 16% was from sales of our border security products and services, and approximately 4% was from SBIR grants for the development of our gas plasma antenna technology. Please refer to the section entitled Amortization of Intangible Assets below regarding our gas plasma technology. There was no revenue from EOIR in the year ended June 30, 2005 as EOIR was not acquired until June 29, 2005.
COST OF REVENUES:
Cost of revenues for the year ended June 30, 2005 was $52,846,275, compared to $4,674,593 for fiscal year 2004. Cost of revenues increased year to year as a result of the acquisition of EOIR which accounted for 99% of the cost of revenues.
Gross profits for the year ended June 30, 2005 was $13,848,512 compared to $1,339,337 for fiscal year 2004. Gross profits increased as a result of additional revenue from the acquisition of EOIR
We had a gross profit margin of approximately 21% for the fiscal year ended June 30, 2005, compared to 22% for the year ended June 30, 2004. http://biz.yah oo.com/e/051012/mrkl.ob10ksb.html
-------------------- It is always darkest before it goes completely BLACK!!! Posts: 2322 | From: FL | Registered: Aug 2004
| IP: Logged |
UBBFriend: Email this page to someone!
Printer-friendly view of this topic
